Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Revel Health vs Spry

Revel Health
Graded #200

Higher grade

vs+9.400000000000006
Spry
Graded #409

Lower grade

The verdict

Revel Health takes it — 66.2/100 to 56.8/100.

Revel Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Revel Health is a telehealth platform combining GLP-1 weight loss with longevity care — semaglutide and tirzepatide plus NAD+, sermorelin and peptide therapy — prescribed by board-certified physicians and…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRevel Health +6
60
54
Dose & formulationEven
64
64
Clinical oversightRevel Health +27
82
55
Labs & monitoringEven
52
52
FulfillmentRevel Health +21
82
61
Contract termsEven
55
55
Revel Health · left barSpry · right bar

The numbers

MetricRevel HealthSpry
WeighScore66.2/10056.8/100
GradeCC
Scorecard rank#200#409
Semaglutide$199/mo (compounded)$199/mo (starting dose, compounded)
Tirzepatide$249/mo (starting dose, compounded)$299/mo (starting dose, compounded)
Coverage45 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Revel Health

Graded #200 · C

Strengths

  • LegitScript certified with board-certified physicians and USP 795/800 compounding
  • Combines GLP-1 weight loss with NAD+, sermorelin and longevity care
  • Fast intake — a physician reviews within the hour
  • Available in 45 states with a clear list of where it operates

Where it loses points

  • Doesn't show upfront pricing — you learn cost during checkout
  • Not available in AK, AR, NC, NJ or MS
  • Compounded medications only — no brand-name options noted
  • Longevity add-ons add cost beyond the core GLP-1 program
Spry

Graded #409 · C

Strengths

  • Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
  • Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
  • Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
  • No contracts or commitment required
  • LegitScript Certified with a public verification link

Where it loses points

  • Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
  • Intake reviewed by a nurse practitioner, not an MD
  • States served not disclosed publicly
  • Pharmacy partner not named, and 503A vs 503B designation not specified
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard